Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated November 9th, 2020

What’s the Risk of Relapse After Non-Hodgkin Lymphoma Treatment?

The risk of relapse after treatment for non-hodgkin lymphoma ranges based on factors including biology of the tumor, stage of cancer, and the patient's age.

NOW
PLAYING
Lung Cancer Patients Who Quit Smoking Live Longer
NOW
PLAYING
Immunocompromised Account for 44% of COVID Cases Among Vaccinated
NOW
PLAYING
Remembering 'Top Chef's' Fatima Ali, Who Passed 2 Years Ago From Cancer: Has There Been Any Progress On Ewing Sarcoma Since?
NOW
PLAYING
Blink-182's Mark Hoppus Has Diffuse Large B-Cell Lymphoma: What Does That Mean, and What Is The Prognosis?
NOW
PLAYING
Understanding the Relationship between IUDs and Cancer Risk
NOW
PLAYING
87% of Eligible Patients Skip Lung Cancer Screening, Analysis Finds

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.